July 5, 2023
A team of UNC researchers have discovered how colon cancer “hijacks” enzyme motif mutations, a finding that may help identify new targets or directions for cancer treatments.
January 18, 2022
Pengda Liu, PhD, was awarded the grant to support his research targeting ATR/SPOP signaling to overcome chemotherapy resistance in Ewing sarcoma, a bone cancer that occurs mainly in children.
November 9, 2021
Pengda Liu, PhD, and Janelle Arthur, PhD, will present their research at the Jefferson-Pilot Fellowships in Academic Medicine and James W. Woods Junior Faculty Award Seminar during UNC Research Week.
June 1, 2021
Pengda Liu, PhD, Ian Davis, MD, PhD, and colleagues have discovered a gene, OTUD7A, that impacts the development of Ewing sarcoma, as well as a compound that shows potential to block OTUD7A protein activity.
May 11, 2021
The University of North Carolina at Chapel Hill is recognizing 118 UNC Lineberger staff and faculty members who will be celebrating a service milestone this year.
September 16, 2020
Qi Zhang, PhD, Robert McGinty, MD, PhD, and team determined the high-resolution structure of a key DNA-sensing protein in the innate immune system called cGAS while it is bound to the nucleosome.
April 19, 2019
The idea was simple: find the faulty signals that drive cancerous growth in cells, and block them. But what University of North Carolina Lineberger Comprehensive Cancer Center researcher Pengda Liu, PhD, has discovered, when it comes to cancer, even straightforward concepts can become complicated. “When you find a target and inhibit it, you find the …
February 11, 2019
UNC Lineberger awarded grants to 14 scientists and research teams in the fall grant awards cycle. Applications for the next round of funding will be due March 15.
